TCW Transform Systems ETF (NETZ)
- Previous Close
72.95 - Open
73.32 - Bid 69.51 x 3000
- Ask 77.14 x 3000
- Day's Range
72.83 - 73.34 - 52 Week Range
51.45 - 76.02 - Volume
8,486 - Avg. Volume
28,007 - Net Assets 150.77M
- NAV 72.76
- PE Ratio (TTM) 26.10
- Yield 0.59%
- YTD Daily Total Return 28.92%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.75%
The fund is an actively managed exchange-traded fund (“ETF”) that seeks to invest in companies that the Adviser believes will benefit from global transformation in the systems supporting how energy and power are sourced, produced, and consumed. It is an actively managed exchange-traded fund (“ETF”) that seeks to invest in companies that the Adviser believes will benefit from global transformation in the systems supporting how energy and power are sourced, produced, and consumed. It is non-diversified.
TCW
Fund Family
Large Blend
Fund Category
150.77M
Net Assets
2022-02-02
Inception Date
Performance Overview: NETZ
View MoreTrailing returns as of 11/1/2024. Category is Large Blend.
People Also Watch
Holdings: NETZ
View MoreTop 10 Holdings (66.26% of Total Assets)
Sector Weightings
Recent News: NETZ
View More
Research Reports: NETZ
View MoreU.S. stocks fell on Thursday on disappointing results from Tech companies.
U.S. stocks fell on Thursday on disappointing results from Tech companies. Both the S&P 500 and the Nasdaq posted their largest one-day losses since the beginning of September. The S&P 500 was down 1.9%, the Nasdaq lost 2.8% and the Dow fell 0.9%. Both crude oil and gold traded higher.
Pfizer Earnings: Maintaining Our Valuation as Management Pressed for Evidence of Productivity
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
RatingPrice TargetSeagate Earnings: Shares Remain Overvalued Despite Higher Short-Term Forecast and Valuation
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.
RatingPrice TargetSeagate Earnings: Cyclical Recovery Drives More Positive Results, but Shares Remain Overvalued
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.
RatingPrice Target